Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum

• Published in: PloS one 2012-10, Vol.7 (10), p.e46207-e46207
• Main Authors: Röpcke, Stefan, Holz, Olaf, Lauer, Gereon, Müller, Meike, Rittinghausen, Susanne, Ernst, Peter, Lahu, Gezim, Elmlinger, Martin, Krug, Norbert, Hohlfeld, Jens M
• Format: Article
• Language: English
• Subjects: Adult; Aged; Alveoli; Analysis; Analysis of Variance; Atherosclerosis; Bioindicators; Biological markers; Biology; Biomarkers; Biomarkers - analysis; Biomarkers - blood; Biomarkers - urine; Biomedical research; Biopsy; Bronchoalveolar lavage; Bronchoalveolar Lavage Fluid - chemistry; Bronchoalveolar Lavage Fluid - cytology; Bronchoscopy; Bronchus; C-Reactive Protein - analysis; Chronic obstructive lung disease; Chronic obstructive pulmonary disease; Clinical trials; Compartments; Correlation; Correlation coefficient; Correlation coefficients; Cytokines - analysis; Cytokines - blood; Desmosine - urine; Development and progression; Female; Gold; Humans; Immunoassay; Inflammation; Interleukin; Interleukin 6; Interleukin-6 - analysis; Interleukin-6 - blood; Isodesmosine - urine; Leukocytes (neutrophilic); Lung - metabolism; Lung - pathology; Lung diseases; Male; Medical research; Medicine; Metabolism; Middle Aged; Neutrophils - cytology; Neutrophils - metabolism; Obstructive lung disease; Patients; Pulmonary Disease, Chronic Obstructive - blood; Pulmonary Disease, Chronic Obstructive - metabolism; Pulmonary Disease, Chronic Obstructive - pathology; Reproducibility; Respiratory tract; Respiratory tract diseases; Singers; Smokers; Smoking; Sputum; Sputum - chemistry; Studies; Time Factors; Toxicology; von Willebrand Factor - analysis
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0046207

Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease, primarily affecting the airways. Stable biomarkers characterizing the inflammatory phenotype of the disease, relevant for disease activity and suited to predict disease progression are needed to monitor the efficacy and safety of drug interventions. We therefore analyzed a large panel of markers in bronchoalveolar lavage, bronchial biopsies, serum and induced sputum of 23 healthy smokers and 24 smoking COPD patients (GOLD II) matched for age and gender. Sample collection was performed twice within a period of 6 weeks. Assays for over 100 different markers were validated for the respective matrices prior to analysis. In our study, we found 51 markers with a sufficient repeatability (intraclass correlation coefficient >0.6), most of these in serum. Differences between groups were observed for markers from all compartments, which extends (von-Willebrand-factor) and confirms (e.g. C-reactive-protein, interleukin-6) previous findings. No correlations between lung and serum markers were observed, including A1AT. Airway inflammation defined by sputum neutrophils showed only a moderate repeatability. This could be improved, when a combination of neutrophils and four sputum fluid phase markers was used to define the inflammatory phenotype.In summary, our study provides comprehensive information on the repeatability and interrelationship of pulmonary and systemic COPD-related markers. These results are relevant for ongoing large clinical trials and future COPD research. While serum markers can discriminate between smokers with and without COPD, they do not seem to sufficiently reflect the disease-associated inflammatory processes within the airways.